Summary
BIONIME Corporation (BIONIME) is a medical device company that offers testing equipment. The company offers self monitoring blood glucose system for biotechnology and medical testing industry. Its products include GM100 series, GM300 series, GM210 series, GM550 series, GM700 series, GS300 test strip, GS100 test strip, GS550 test strip, GP300 PC link, GS210 test strip, GP550 PC link, GS700 test strip and GD500 lancet device. BIONIME provides technical support services. The company develops technology platform in the fields of chemistry, electronics and precision mechanism. It operates in the Middle East, Europe, America, Asia and Australia. BIONIME is headquartered in Taichung, Taiwan.
BIONIME Corporation (4737) - Medical Equipment - Deals and Alliances Profile provides you comprehensive data and trend analysis of the company's Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.
GlobalData derived the data presented in this report from proprietary in-house Medical eTrack deals database, and primary and secondary research.
Scope
- Financial Deals - Analysis of the company's financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year - Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type - Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region - Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector - Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals - Information on the company's major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description - A brief description of the company's operations.
- Key Employees - A list of the key executives of the company.
- Important Locations and Subsidiaries - A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors - A list of the key competitors of the company.
- Key Recent Developments - A brief on recent news about the company.
Reasons to Buy
Get detailed information on the company's financial deals that enable you to understand the company's expansion/divestiture and fund requirements
- The profile enables you to analyze the company's financial deals by region, by year, by business segments and by type, for a five year period.
Understand the company's business segments' expansion / divestiture strategy
- The profile presents deals from the company's core business segments' perspective to help you understand its corporate strategy.
Access elaborate information on the company's recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company's key financial metrics and ratios.
Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company's business structure, locations and subsidiaries, key executives and key competitors.
Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.
Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.
Note*: Some sections may be missing if data is unavailable for the company.
'
Table of Contents
Table of Contents 2
List of Tables 3
List of Figures 4
BIONIME Corporation, Medical Equipment, Deals By Year, 2010 to YTD 2016 5
BIONIME Corporation, Medical Equipment Deals By Type, 2010 to YTD 2016 6
BIONIME Corporation, Medical Equipment, Deals By Region, 2010 to YTD 2016 7
BIONIME Corporation, Medical Equipment, Deals By Market, 2010 to YTD 2016 8
BIONIME Corporation, Medical Equipment, Deals Summary, 2010 to YTD 2016 9
BIONIME Corporation, Medical Equipment, Deal Details 10
Partnerships 10
GE Healthcare Enters Into Licensing Agreement With BIONIME For Diabetes Solutions 10
Bionime And Ypsomed Enter Into Agreement To Market Blood Glucose Monitoring Products 11
Equity Offering 12
Bionime Prices Private Placement of Shares for USD36.6 Million 12
BIONIME Announces Public Offering For US$9.8 Million 14
Debt Offering 15
BIONIME Announces Private Placement Of Unsecured Convertible Corporate Bonds For US$14 Million 15
BIONIME Corporation - Key Competitors 16
Key Employees 17
Locations And Subsidiaries 18
Head Office 18
Other Locations & Subsidiaries 18
Appendix 19
Methodology 19
About GlobalData 19
Contact Us 19
Disclaimer 19
List of Tables
BIONIME Corporation, Medical Equipment, Key Facts, 2014 1
BIONIME Corporation, Medical Equipment, Deals Summary, 2010 to YTD 2016 1
BIONIME Corporation, Medical Equipment, Deals By Year, 2010 to YTD 2016 5
BIONIME Corporation, Medical Equipment Deals By Type, 2010 to YTD 2016 6
BIONIME Corporation, Medical Equipment, Deals By Region, 2010 to YTD 2016 7
BIONIME Corporation, Deals By Market, 2010 to YTD 2016 8
BIONIME Corporation, Medical Equipment, Deals Summary, 2010 to YTD 2016 9
GE Healthcare Enters Into Licensing Agreement With BIONIME For Diabetes Solutions 10
Bionime And Ypsomed Enter Into Agreement To Market Blood Glucose Monitoring Products 11
Bionime Prices Private Placement of Shares for USD36.6 Million 12
BIONIME Announces Public Offering For US$9.8 Million 14
BIONIME Announces Private Placement Of Unsecured Convertible Corporate Bonds For US$14 Million 15
BIONIME Corporation, Key Competitors 16
BIONIME Corporation, Key Employees 17
BIONIME Corporation, Subsidiaries 18
List of Figures
BIONIME Corporation, Medical Equipment, Deals by Type, 2010 to YTD 2016 1
BIONIME Corporation, Medical Equipment, Deals By Year, 2010 to YTD 2016 1
BIONIME Corporation, Medical Equipment, Deals By Region, 2010 to YTD 2016 1
BIONIME Corporation, Medical Equipment, Deals By Market, 2010 to YTD 2016 1
BIONIME Corporation, Medical Equipment, Deals By Year, 2010 to YTD 2016 5
BIONIME Corporation, Medical Equipment, Deals by Type, 2010 to YTD 2016 6
BIONIME Corporation, Medical Equipment, Deals By Region, 2010 to YTD 2016 7
BIONIME Corporation, Medical Equipment, Deals by Market, 2010 to YTD 2016 8